Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Beinart GA, Gonzalez-Angulo AM, Broglio K, Frye D, Walters R, Holmes FA, Gunale S, Booser D, Rosenthal J, Dhingra K, Young JA, Hortobagyi GN.
Beinart GA, et al.
Cancer Chemother Pharmacol. 2007 Jun;60(1):61-7. doi: 10.1007/s00280-006-0348-9. Epub 2006 Sep 29.
Cancer Chemother Pharmacol. 2007.
PMID: 17009032
Clinical Trial.